Delirium
Conditions
Keywords
Cardiac Surgery, Post-operative Delirium, Coronary Artery Bypass Grafting, EuroSCORE II
Brief summary
The goal of this observational study is to find out the association between EuroSCORE II of Delirium in patients undergoing cardiac surgery. The main questions it aims to answer are the incidence of Delirium in patients undergoing cardiac surgery and to find the association of EuroSCORE II with delirium in cardiac surgery patients.
Interventions
* EuroSCORE II is used to predict the risk of in-hospital mortality after cardiac surgery. Where very low risk is \<1, low risk is 1-2.99, moderate risk is 3-4.99, and high risk is \>5. * CAM- ICU: The Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) is a tool used to assess delirium in patients in intensive care. The score ranges from 0-. Where 0-2 is no delirium, ≥ 3 is positive for delirium, 3-5 mild delirium, 6-7 severe delirium with 7 considered most severe delirium.
Sponsors
Study design
Eligibility
Inclusion criteria
* Age greater than or equal to 18 years * ASA I -IV * Patients undergoing elective cardiac surgery
Exclusion criteria
* Patients undergoing emergency cardiac surgeries * History of stroke in the last 6 weeks * History of delirium * History of psychiatric illness * history of medication for psychiatric illness * Patients undergoing reopen surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of Participants With Delirium | Day 1 | As per DSM 5 criteria delirium is an acute condition. Symptoms begin over a few hours or a few days. Delirium will be assessed by CAM-ICU score. |
| Association of Euroscore II Category With Delirium | Day 1 | — |
Countries
Pakistan
Baseline characteristics
| Characteristic | — |
|---|---|
| Age, Continuous | 55.93 years STANDARD_DEVIATION 9.827 |
| Sex: Female, Male Female | 24 Participants |
| Sex: Female, Male Male | 76 Participants |
Adverse events
| Event type | EG000 affected / at risk |
|---|---|
| deaths Total, all-cause mortality | 0 / 100 |
| other Total, other adverse events | 0 / 100 |
| serious Total, serious adverse events | 0 / 100 |